[go: up one dir, main page]

ES2141351T3 - Nuevo principio activo peptidico y su obtencion. - Google Patents

Nuevo principio activo peptidico y su obtencion.

Info

Publication number
ES2141351T3
ES2141351T3 ES95917963T ES95917963T ES2141351T3 ES 2141351 T3 ES2141351 T3 ES 2141351T3 ES 95917963 T ES95917963 T ES 95917963T ES 95917963 T ES95917963 T ES 95917963T ES 2141351 T3 ES2141351 T3 ES 2141351T3
Authority
ES
Spain
Prior art keywords
pct
obtaining
active principle
val
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95917963T
Other languages
English (en)
Inventor
Wilhelm Amberg
Harald Bernard
Ernst Buschmann
Andreas Haupt
Lothar Janitschke
Bernd Janssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2141351T3 publication Critical patent/ES2141351T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE DESCRIBE EL COMPUESTO ME 2 VAL-VAL-MEVAL-PRO-PRONHBZL.HCL. SE OBTIENEN A PARTIR DE Z-VAL-VAL-MEVAL-PRO-OR{SUP,1}, EN DONDE Z Y R{SUP,1} TIENEN EL SIGNIFICADO DADO EN LA DESCRIPCION. EL COMPUESTO POSEE ACTIVIDAD ANTINEOPLASTICA.
ES95917963T 1994-05-06 1995-04-26 Nuevo principio activo peptidico y su obtencion. Expired - Lifetime ES2141351T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4415997A DE4415997A1 (de) 1994-05-06 1994-05-06 Neuer peptidischer Wirkstoff und dessen Herstellung

Publications (1)

Publication Number Publication Date
ES2141351T3 true ES2141351T3 (es) 2000-03-16

Family

ID=6517453

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95917963T Expired - Lifetime ES2141351T3 (es) 1994-05-06 1995-04-26 Nuevo principio activo peptidico y su obtencion.

Country Status (28)

Country Link
US (1) US5864012A (es)
EP (1) EP0758342B1 (es)
JP (1) JPH09512803A (es)
KR (1) KR100336139B1 (es)
CN (1) CN1113067C (es)
AT (1) ATE188485T1 (es)
AU (1) AU688037B2 (es)
BG (1) BG61610B2 (es)
BR (1) BR9507623A (es)
CZ (1) CZ288448B6 (es)
DE (2) DE4415997A1 (es)
DK (1) DK0758342T3 (es)
ES (1) ES2141351T3 (es)
FI (1) FI119642B (es)
GR (1) GR3032630T3 (es)
HR (1) HRP950271B1 (es)
HU (1) HU220875B1 (es)
IL (1) IL113544A (es)
MX (1) MX9605402A (es)
NO (1) NO317728B1 (es)
NZ (1) NZ285092A (es)
PL (1) PL180652B1 (es)
PT (1) PT758342E (es)
RU (1) RU2153504C2 (es)
SI (1) SI9520061B (es)
TW (1) TW408132B (es)
WO (1) WO1995030691A1 (es)
ZA (1) ZA953584B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US7304750B2 (en) * 1999-12-17 2007-12-04 Nektar Therapeutics Systems and methods for non-destructive mass sensing
KR20020066476A (ko) * 2001-02-12 2002-08-19 쥬가이 세이야쿠 가부시키가이샤 펩타이드 유도체의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292612B6 (cs) * 1992-05-20 2003-11-12 Abbott Gmbh & Co. Kg Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu

Also Published As

Publication number Publication date
HUT75861A (en) 1997-05-28
CN1113067C (zh) 2003-07-02
US5864012A (en) 1999-01-26
GR3032630T3 (en) 2000-05-31
CZ326096A3 (en) 1997-04-16
BR9507623A (pt) 1997-10-07
AU2408395A (en) 1995-11-29
PT758342E (pt) 2000-04-28
CZ288448B6 (en) 2001-06-13
SI9520061B (sl) 2002-02-28
AU688037B2 (en) 1998-03-05
EP0758342B1 (de) 2000-01-05
IL113544A0 (en) 1995-07-31
HRP950271B1 (en) 2000-08-31
NO964688D0 (no) 1996-11-05
DE59507578D1 (de) 2000-02-10
FI964448A (fi) 1996-11-05
HU220875B1 (en) 2002-06-29
RU2153504C2 (ru) 2000-07-27
PL321159A1 (en) 1997-11-24
TW408132B (en) 2000-10-11
CN1162318A (zh) 1997-10-15
HU9603067D0 (en) 1997-01-28
DK0758342T3 (da) 2000-05-01
ATE188485T1 (de) 2000-01-15
KR100336139B1 (ko) 2002-09-25
IL113544A (en) 2001-01-11
NZ285092A (en) 1998-01-26
NO964688L (no) 1997-01-02
JPH09512803A (ja) 1997-12-22
KR970702880A (ko) 1997-06-10
SI9520061A (en) 1997-06-30
WO1995030691A1 (de) 1995-11-16
HRP950271A2 (en) 1997-08-31
ZA953584B (en) 1996-11-04
PL180652B1 (pl) 2001-03-30
EP0758342A1 (de) 1997-02-19
FI964448A0 (fi) 1996-11-05
MX9605402A (es) 1997-12-31
FI119642B (fi) 2009-01-30
DE4415997A1 (de) 1995-11-09
BG61610B2 (bg) 1998-01-30
NO317728B1 (no) 2004-12-13

Similar Documents

Publication Publication Date Title
CY2473B1 (en) New phenanthridines.
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
NO992282D0 (no) Benzonaftyridiner som bronkialterapentika
AU3115395A (en) Dihydrobenzofuranes
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
GR3024667T3 (en) Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use.
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
TR199901386T2 (en) �midazopiridazinler.
ES2141351T3 (es) Nuevo principio activo peptidico y su obtencion.
DE69319337D1 (en) Polyetheramidoamine hydrogele als heparinersatz
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
ES2166811T3 (es) Amino-alquil-amino-piridinas sustituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 758342

Country of ref document: ES